Value-Based Care and Resource Stewardship

You cannot improve value you do not measure. The measurement half of value-based care rests on outcomes, and the gold-standard outcomes are those the patient experiences — pain, function and quality of life captured by validated patient-reported outcome measures (PROMs) such as the Oxford Hip and Knee scores, HOOS/KOOS, and the generic PROMIS — tracked alongside the cost and the time taken to deliver them. The full value picture for an orthopaedic episode is therefore outcomes plus cost plus time, measured across the whole care cycle.

National arthroplasty registries are the clearest working example of value measurement in orthopaedics. They capture every joint replacement in a country and report implant survival and revision rates against a common yardstick, which lets the system detect underperforming implants early, drive them out, and standardise high-value pathways:

What registries expose is unwarranted variation — differences in practice and outcome that cannot be explained by patient need. Variation without a clinical reason is, by definition, waste: some patients are getting too much of something and others too little, with no difference in need to justify it. Measuring outcomes across a whole population turns stewardship from an opinion into a discipline, because it lets you show, with data, where the low-value practice actually sits. Using registry and outcome data ethically — protecting patient identity, reporting honestly, and acting on the signal — sits within the broader research-ethics tradition of the Declaration of Helsinki, which insists that evidence used to guide care be generated and reported honestly. [10]

When a resource is genuinely scarce — a single emergency theatre at night, a limited stock of a specific implant, a finite number of inpatient beds, or the next trauma list — the question stops being about cost-effectiveness and becomes one of distributive justice: how is a fair share decided? Examiners want you to separate the level at which the decision is made from the criteria used to make it.

Most of the choices you will defend in a viva are micro-allocation decisions, and the criteria that make them fair are well established. A defensible allocation weighs need (how badly the patient requires the resource), expected benefit (how much good the resource is likely to do), urgency (how soon it must be given to matter), and equity (giving similar patients similar chances). When patients are otherwise indistinguishable on these criteria, a lottery or first-come basis is used as an explicit, transparent tiebreaker — not because it is perfect, but because it is fair in the only remaining sense and is open to scrutiny. Tools such as the quality-adjusted life-year and cost-effectiveness analysis offer one quantitative input into these judgements, but they are contested on equity grounds — they can undervalue the elderly, the disabled and those with shorter baseline life expectancy — so they inform rather than replace the clinician's moral judgement.

What makes an allocation defensible is not only the outcome but the process. Procedural justice demands that the rule be transparent, consistent (the same rule for everyone), relevant to the purpose (allocating by need, not by status), and appealable (a patient can ask for a decision to be reviewed). Patients and colleagues will accept an outcome they disagree with if they can see the rule was applied fairly; they will not accept an outcome — however efficient — that looks arbitrary or self-serving. Say the rule out loud, apply it the same way every time, and you can defend any individual decision.

Appropriate-use and stewardship meet the law at the point of consent. Two lines of authority run underneath everyday orthopaedic practice, and a professionalism candidate is expected to know both: the standard expected of a competent surgeon, and the standard expected of an honest conversation with a patient.

The stewardship point of Montgomery is that what counts as an "appropriate" treatment is partly a judgement the patient is entitled to share in. [5] You must present the reasonable alternatives — including doing nothing, or trying conservative care first — with their material risks and benefits, so the patient can weigh a lower-value, lower-risk option against a higher-value, higher-risk one. The stewardship point of Bolam and Bolitho is that the defence for what you did rests on a responsible body of opinion that survives logical analysis: a practice cannot be justified merely because "everyone does it" if it cannot be reasoned through, and a cost-driven shortcut that no reasonable body would endorse is not protected. [6] Together, the two standards make stewardship safe: you reduce low-value care and present alternatives honestly, but you never drop below an evidence-based standard of care to save money.

Much of what we call stewardship is delivered not by individual heroism but by reliable systems — because reliable systems prevent the complications, readmissions and revisions that are the most expensive form of waste. Two ideas anchor this section.

The first is the WHO Surgical Safety Checklist, a short, low-cost tool that teams run through before anaesthesia, before skin incision, and before the patient leaves theatre. [2] Its importance to value is that a virtually costless intervention produces large outcome gains — in a global multi-site study its introduction was associated with a fall in complications and inpatient deaths — exactly the kind of high-value change that improves outcomes while lowering the downstream cost of harm.

The second is the systems model of human error: harm rarely comes from a single reckless individual; it comes from the alignment of latent gaps in several defensive layers, the "Swiss-cheese" model. [4] The implication for stewardship is that value is built by design — checklists, standardised pathways, team training, briefings and debriefings — rather than by exhorting individuals to try harder. A well-designed system wastes less, because it catches errors before they become complications, and complications are where the money and the harm both concentrate.

Reliable communication is part of the same system. Structured handover using ISBAR — Identify, Situation, Background, Assessment, Recommendation — cuts the information loss at shift changes and transfers that drives delay, duplicated investigation and error. Honest communication extends to disclosure when things go wrong: the professional duty of candour (and its equivalents, such as open-disclosure frameworks) requires telling a patient promptly and fully when they have been harmed, which is both an ethical obligation and the precondition for the system learning that prevents the next patient being harmed the same way.

Stewardship cannot be separated from conflicts of interest and the duty to speak up. A surgeon who gains financially from using a particular implant, from the volume of surgery performed, or from ownership of an imaging or rehabilitation facility has an interest that may diverge from the patient's, and that interest must be disclosed and managed — not because the surgeon is assumed dishonest, but because transparency is the safeguard that keeps trust intact. The AAOS and royal-college codes place disclosure and management of conflicts squarely within professional conduct. [9]

The same obligation runs towards the conduct of colleagues. If a clinician believes a colleague is delivering care that is consistently low-value, unnecessary, or below standard, the professional duty is to act proportionately — raising the concern through the local pathway first, escalating if patient safety is at risk, and always in the patient's interest rather than from personal grievance. Speaking up about waste and about unsafe practice is the same duty seen from two sides: stewardship is, in the end, accountability for the resource and the trust placed in the profession.

In its modern form, value is the patient health outcomes achieved per unit of cost over the full cycle of care for a condition. [1] The crucial move in this definition is that it puts outcomes in the numerator and cost in the denominator, so the way to raise value is either to improve outcomes or to lower the total cost of care — and it judges cost over the whole episode, not the sticker price of a single implant. A cheaper prosthesis that fails early and needs revision is low-value, however little it cost to buy; a more expensive implant with measurably better long-term survival and patient-reported function may be high-value.

The cost that matters for value is the total cost of looking after the condition — the implant, the theatre time, the length of stay, the complications, the readmissions, the revision surgery. Cutting one line item in a way that pushes cost elsewhere or harms the patient does not create value, it destroys it. This is why examiners are wary of a candidate who equates "value" with "cheap": that is cost-containment, not value-based care, and the two diverge whenever a saving is bought at the expense of an outcome.

Resource stewardship is the ethical and professional half of the same idea. Orthopaedic care draws on finite shared resources — theatre hours, inpatient beds, blood, implants, imaging, and the working time and attention of the team. A steward holds something in trust for others and is accountable for using it well. The surgeon is a steward of the resources society has invested in health care, and that role is now written into the professional codes of every major system: the GMC tells doctors to make good use of the resources available to them, the AAOS places stewardship within its standards of professional conduct, and equivalent obligations run through AO Foundation, EFORT and royal-college guidance worldwide. [9]

Examiners test this domain because every health system is cost-pressured and because a surgeon who cannot frame a decision in terms of value is unprepared for modern practice — and for the professionalism viva. The candidate who wins marks names the value equation, separates overuse from underuse, distinguishes necessary cost-reduction from value-destroying rationing, and can allocate a scarce resource out loud using a fair and defensible rule.

The single idea to carry through the rest of the page: higher valuevia better outcomes or lower total cost is the goal — and waste, the resource spent without benefit or with net harm, is the common enemy of patients and systems alike.

A viva answer on stewardship is built on a recognised ethical scaffold, not on personal opinion. The scaffold examiners expect is the four-principles approach of Beauchamp and Childress, [7] applied with the population-health aims of the Triple Aim (better care for individuals, better health for populations, and lower per-capita cost — later extended by a fourth aim, clinician wellbeing). The four principles give you a shared moral vocabulary; the aims give you the system-level outcomes to steer towards.

Justice is the spine of stewardship — it is the principle that asks how a fair share of a finite resource is determined — but it never acts alone. Autonomy stops you withholding information to steer a patient towards a cheaper option. Beneficence and non-maleficence stop you substituting cost for quality. The four principles are designed to be balanced and specified against the case in front of you, and a strong answer names which principles are in tension before it resolves them.

The part of waste a surgeon controls most directly is overuse — care that offers no benefit or net harm to the patient. Overuse is one of the recognised categories of health-system waste, alongside failures of care delivery and coordination, administrative complexity, pricing failures and fraud. [3] The bedside instruments for cutting overuse are appropriate-use criteria and the Choosing Wisely movement.

Appropriate-use criteria match an intervention to a specific clinical situation, so that a test or operation is recommended when the expected benefit justifies the risk and cost, and discouraged when it does not. Choosing Wisely, launched by the ABIM Foundation, asks each specialty to publish a short list of tests and treatments that clinicians and patients should question because the evidence shows no benefit or net harm. [8] The orthopaedic and musculoskeletal lists are explicitly clinician-owned — they are stewardship delivered by the profession rather than imposed on it — and they target the exact overuse that destroys value.

Representative Choosing Wisely recommendations for orthopaedic practice include avoiding an intra-articular corticosteroid injection in the months immediately before an elective arthroplasty (because of the infection risk), avoiding advanced imaging for uncomplicated acute low back pain before assessment for red flags, limiting postoperative antibiotic prophylaxis to the shortest evidence-based course, and prescribing opioids for musculoskeletal pain only with a risk-mitigation plan. [8] Each removes a measured harm from the patient and a measured cost from the system at the same time — the definition of high-value change.

The mirror image of overuse is underuse — failing to provide care that would clearly benefit the patient. Underuse is just as much a value failure as overuse: a displaced femoral neck fracture in a fit patient that is left in pain rather than operated, or a high-energy plateau fracture managed on plain films alone without the CT that changes the plan, sacrifices outcomes and often costs more in the long run through avoidable complications. Stewardship cuts both ways; the surgeon who "conserves resource" by under-treating is not a steward, just a different kind of poor-value provider.

Everything below condenses the topic for revision and viva practice — the points that win marks, the memory hooks, three worked vivas, and a one-screen cheat sheet.